We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Arterial Gas Analyzer and Autoanalyzer Compared for Electrolytes

By LabMedica International staff writers
Posted on 28 Mar 2013
Electrolyte values are measured in most critically ill intensive care unit (ICU) patients using both an arterial blood gas analyzer (ABG) and a central laboratory autoanalyzer (AA). More...


Data on sodium and potassium ion concentrations in ICU patients have been examined to see whether the electrolyte levels assessed by the ABG and the AA are equivalent and reliable.

Scientists at the Sevket Yilmaz Education and Research Hospital (Bursa, Turkey) retrospectively studied patients hospitalized in the ICU between July and August 2011. They identified 84 instances, of 1,105 patient blood gas samples analyzed, in which arterial and venous samples were collected simultaneously and sodium (Na+) and (K+) were measured using two methods.

In the ICU, arterial blood samples were collected in heparinized blood-gas syringes and analyzed using the benchtop pHOx Stat Profile Plus L blood–gas analyzer (Nova Biomedical; Waltham MA, USA) which employs direct ion-specific electrode (ISE) technology. Another sample was drawn, at the same time, from the same arterial sampling point, using a vacuum technique featuring clot-activating tubes. These samples were sent, pneumatically sealed, to the central laboratory, where serum Na+ and K+ concentrations were analyzed via indirect ISE on a Modular ISE900 auto-analyzer (Roche Diagnostics; Mannheim, Germany).

The mean sodium concentration was 138.mmol/L (standard deviation, SD ±10.2 mmol/L) using the ABG and 143.0 mmol/L (SD ±10.5 mmol/L) using the AA, which was statistically different. The mean potassium level was 3.5mmol/L (SD ± 0.9 mmol/L) using the ABG and 3.7 mmol/L (SD ± 1.0 mmol/L) using the AA which was also significantly different. The extent of interanalyzer agreement was unacceptable for both K+ and Na+. The between-day imprecision of both instruments (AA and ABG) was small and lacked clinical significance when compared with analytical performance indicators based on biological variation.

The authors concluded that their study illustrates the importance of determining the concordance, for each individual hospital, of electrolyte values obtained by ABG and those obtained in the central laboratory. As instrument type and calibration methods may differ among hospitals, it is important that each center conducts an in-house study as in their study the ABG and AA do not yield equivalent Na+ and K+ data. The study was published on August 3, 2012, in the BioMed Central journal BMC Anesthesiology.

Related Links:

Sevket Yilmaz Education and Research Hospital
Nova Biomedical
Roche




Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.